Literature DB >> 28089850

Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis.

Sonja Kroep1, Curtis R Heberle2, Kit Curtius3, Chung Yin Kong4, Iris Lansdorp-Vogelaar1, Ayman Ali2, W Asher Wolf5, Nicholas J Shaheen5, Stuart J Spechler6, Joel H Rubenstein7, Norman S Nishioka8, Stephen J Meltzer9, William D Hazelton10, Marjolein van Ballegooijen1, Angela C Tramontano11, G Scott Gazelle4, E Georg Luebeck10, John M Inadomi12, Chin Hur13.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28089850      PMCID: PMC5507756          DOI: 10.1016/j.cgh.2016.12.034

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  4 in total

1.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

2.  Calibration of disease simulation model using an engineering approach.

Authors:  Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

3.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

4.  Trends in esophageal adenocarcinoma incidence and mortality.

Authors:  Chin Hur; Melecia Miller; Chung Yin Kong; Emily C Dowling; Kevin J Nattinger; Michelle Dunn; Eric J Feuer
Journal:  Cancer       Date:  2012-12-11       Impact factor: 6.860

  4 in total
  13 in total

1.  Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma.

Authors:  Fatemeh G Amlashi; Xuemei Wang; Raquel E Davila; Dipen M Maru; Manoop S Bhutani; Jeffrey H Lee; Brian R Weston; Dilsa Mizrak Kaya; Maria Vassilakopoulou; Kazuto Harada; Mariela A Blum Murphy; David C Rice; Wayne L Hofstetter; Marta Davila; Quynh-Nhu Nguyen; Jaffer A Ajani
Journal:  Oncology       Date:  2018-05-29       Impact factor: 2.935

Review 2.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

3.  High rate of missed Barrett's esophagus when screening with forceps biopsies.

Authors:  Mendel E Singer; Robert D Odze
Journal:  Esophagus       Date:  2022-07-22       Impact factor: 3.671

4.  The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management.

Authors:  Amir-Houshang Omidvari; Carlijn A M Roumans; Steffie K Naber; Sonja Kroep; Bas P L Wijnhoven; Ate van der Gaast; Pieter-Jan de Jonge; Manon C W Spaander; Iris Lansdorp-Vogelaar
Journal:  Am J Gastroenterol       Date:  2020-07       Impact factor: 10.864

5.  Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling.

Authors:  Amir-Houshang Omidvari; Ayman Ali; William D Hazelton; Sonja Kroep; Minyi Lee; Steffie K Naber; Brianna N Lauren; Sassan Ostvar; Ellen Richmond; Chun Yin Kong; Joel H Rubenstein; Iris Lansdorp-Vogelaar; Georg Luebeck; Chin Hur; John Inadomi
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-06       Impact factor: 13.576

6.  Evidence-based sizing of non-inferiority trials using decision models.

Authors:  Iris Lansdorp-Vogelaar; Reshma Jagsi; Jinani Jayasekera; Natasha K Stout; Sandra A Mitchell; Eric J Feuer
Journal:  BMC Med Res Methodol       Date:  2019-01-07       Impact factor: 4.615

7.  Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.

Authors:  Angela C Tramontano; Yufan Chen; Tina R Watson; Andrew Eckel; Chin Hur; Chung Yin Kong
Journal:  Cancer Med       Date:  2019-07-26       Impact factor: 4.452

8.  Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening.

Authors:  Mendel E Singer; Michael S Smith
Journal:  Dig Dis Sci       Date:  2020-06-23       Impact factor: 3.199

9.  Computational modelling suggests that Barrett's oesophagus may be the precursor of all oesophageal adenocarcinomas.

Authors:  Kit Curtius; Joel H Rubenstein; Amitabh Chak; John M Inadomi
Journal:  Gut       Date:  2020-11-24       Impact factor: 31.793

Review 10.  Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management.

Authors:  Vedha Sanghi; Hina Amin; Madhusudhan R Sanaka; Prashanthi N Thota
Journal:  World J Gastrointest Endosc       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.